Raising hematology's European voice: the importance of calling yourself a hematologist.
作者信息
de Wit Thom Duyvené, Borkhardt Arndt, Chomienne Christine, Döhner Hartmut, Fibbe Willem E, Foà Robin, Hagenbeek Anton, Skoda Radek C, Smand Carin R, Jäger Ulrich
出版信息
Haematologica. 2012 Apr;97(4):476-8. doi: 10.3324/haematol.2011.057257.
Abstract
摘要
相似文献
1
Raising hematology's European voice: the importance of calling yourself a hematologist.发出血液学领域的欧洲声音：自称血液学家的重要性。
Haematologica. 2012 Apr;97(4):476-8. doi: 10.3324/haematol.2011.057257.
2
25th European Hematology Association Annual Congress.
Lancet Haematol. 2020 Aug;7(8):e561-e562. doi: 10.1016/S2352-3026(20)30214-3. Epub 2020 Jun 29.
3
The European Hematology Association: strengthening hematology in Europe and beyond.欧洲血液学协会：加强欧洲及其他地区的血液学。
Expert Rev Hematol. 2011 Apr;4(2):133-6. doi: 10.1586/ehm.11.15.
4
Reflections on 45 years as a clinical hematologist.作为一名临床血液学家的45年反思。
Clin Adv Hematol Oncol. 2020 Mar;18(3):160-161.
5
Third meeting of the European Association for Haematopathology, Würzburg, 7-11 October 1990.欧洲血液病理学协会第三次会议，维尔茨堡，1990年10月7日至11日。
Pathol Res Pract. 1991 May;187(4):522-4. doi: 10.1016/S0344-0338(11)80019-1.
6
[The general hematologist].[普通血液科医生]
Sangre (Barc). 1995 Jun;40(3):228-9.
7
20th Congress of European Hematology Association.欧洲血液学协会第20届大会
Lancet Haematol. 2015 Jul;2(7):e274-5. doi: 10.1016/S2352-3026(15)00118-0. Epub 2015 Jul 1.
8
Abstracts. Seventh annual meeting. The European Society for Paediatric Haematology and Immunology. Oslo, Norway, June 11-13, 1979.摘要。第七届年会。欧洲儿科血液学和免疫学协会。挪威奥斯陆，1979年6月11日至13日。
Pediatr Res. 1979 Aug;13(8):948-57. doi: 10.1203/00006450-197908000-00020.
9
[Changes in the diagnostic and treatment strategies of patients with hematological diseases during the COVID-19 pandemic with reference to recommendations from American Society of Hematology and European Hematology Association].[参照美国血液学会和欧洲血液学协会的建议，COVID-19大流行期间血液病患者诊断和治疗策略的变化]
Rinsho Ketsueki. 2021;62(2):101-105. doi: 10.11406/rinketsu.62.101.
10
[25 years of advances in hematology].[血液学25年的进展]
Pol Tyg Lek. 1976 Dec 13;31(50):2151-4.
引用本文的文献
1
The role of hematologists in a changing United States health care system.血液科医生在美国不断变化的医疗保健系统中的作用。
Blood. 2015 Apr 16;125(16):2467-70. doi: 10.1182/blood-2014-12-615047. Epub 2015 Mar 6.
本文引用的文献
1
Large-scale expansion and exploitation of pluripotent stem cells for regenerative medicine purposes: beyond the T flask.大规模扩增和利用多能干细胞进行再生医学目的：超越 T 瓶。
Regen Med. 2012 Jan;7(1):71-84. doi: 10.2217/rme.11.101.
2
Anti-CD20 monoclonal antibodies: historical and future perspectives.抗 CD20 单克隆抗体：历史与未来展望。
Haematologica. 2010 Jan;95(1):135-43. doi: 10.3324/haematol.2008.001628. Epub 2009 Sep 22.
3
DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome.细胞遗传学正常的急性髓系白血病基因组的DNA测序
Nature. 2008 Nov 6;456(7218):66-72. doi: 10.1038/nature07485.
4
Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality.欧洲的静脉血栓栓塞症（VTE）。VTE事件的数量以及相关的发病率和死亡率。
Thromb Haemost. 2007 Oct;98(4):756-64. doi: 10.1160/TH07-03-0212.
5
New tyrosine kinase inhibitors in chronic myeloid leukemia.慢性髓性白血病中的新型酪氨酸激酶抑制剂
Haematologica. 2005 Apr;90(4):534-41.
6
Bone marrow transplantation from the personal viewpoint.从个人角度看骨髓移植
Int J Hematol. 2005 Feb;81(2):89-93. doi: 10.1532/ijh97.04197.
7
Chronic lymphocytic leukaemia. Current strategy and new perspectives of treatment.慢性淋巴细胞白血病。当前治疗策略与新展望
Haematologica. 1999 Jun;84 Suppl EHA-4:94-5.
8
Diagnosis, front line treatment and molecular monitoring of acute promyelocytic leukaemia.急性早幼粒细胞白血病的诊断、一线治疗及分子监测
Haematologica. 1999 Jun;84 Suppl EHA-4:72-4.
9
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells.Abl酪氨酸激酶选择性抑制剂对Bcr-Abl阳性细胞生长的影响。
Nat Med. 1996 May;2(5):561-6. doi: 10.1038/nm0596-561.
Zotero 插件